Evidence map›Paper›PMID 20964406›Full record

ArticleJournal of medicinal chemistry2010

Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses.

Runzhi Wu, Eric D Smidansky, Hyung Suk Oh, Ratree Takhampunya, Radhakrishnan Padmanabhan, Craig E Cameron, Blake R Peterson

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Molecules (Basel, Switzerland) · 2024
    Review
  5. Broad spectrum antiviral nucleosides-Our best hope for the future.Annual reports in medicinal chemistry · 2021
    Article
  6. Article
  7. Escape of Tick-Borne Flavivirus from 2'-Journal of virology · 2017
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Runzhi WuDepartment of Medicinal Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA.
Eric D Smidansky
Hyung Suk Oh
Ratree Takhampunya
Radhakrishnan Padmanabhan
Craig E Cameron
Blake R Peterson
Pennsylvania State University · USGeorgetown University · USUniversity of Kansas · US

Funding

RNA DEPENDENT RNA POLYMERASE MECHANISMR01AI045818 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ARNOLD, JAMIE JON, CAMERON, CRAIG E. · 1999 to 2025
$7.5M
Lethal Mutagenesis as an Antiviral StrategyU01AI054776 · NIAID · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI CAMERON, CRAIG E. · 2003 to 2007
$3.1M
Development of Antiviral Therapeutics for Dengue: Inhibitors of Viral ProteaseU01AI082068 · NIAID · GEORGETOWN UNIVERSITY · PI PADMANABHAN, RADHAKRISHNAN · 2009 to 2010
$1.2M
Identification and Analysis of Flavivirus Protease and RNA Helicase InhibitorsR01AI070791 · NIAID · GEORGETOWN UNIVERSITY · PI PADMANABHAN, RADHAKRISHNAN · 2006 to 2009
$1.1M
NIAID NIH HHS AI054776NIAID NIH HHS AI070791NIAID NIH HHS AI082068NIAID NIH HHS R01 AI045818NIAID NIH HHS R01 AI070791NIAID NIH HHS U01 AI054776NIAID NIH HHS U01 AI082068
6 · The paper itself

Abstract

Bioisosteric deaza analogues of 6-methyl-9-β-D-ribofuranosylpurine, a hydrophobic analogue of adenosine, were synthesized and evaluated for antiviral activity. Whereas the 1-deaza and 3-deaza analogues were essentially inactive in plaque assays of infectivity, a novel 7-deaza-6-methyl-9-β-D-ribofuranosylpurine analogue, structurally related to the natural product tubercidin, potently inhibited replication of poliovirus (PV) in HeLa cells (IC(50) = 11 nM) and dengue virus (DENV) in Vero cells (IC(50) = 62 nM). Selectivity against PV over cytotoxic effects to HeLa cells was >100-fold after incubation for 7 h. Mechanistic studies of the 5'-triphosphate of 7-deaza-6-methyl-9-β-D-ribofuranosylpurine revealed that this compound is an efficient substrate of PV RNA-dependent RNA polymerase (RdRP) and is incorporated into RNA mimicking both ATP and GTP.

Indexed as

AdenosineAntiviral AgentsCell LineDengue VirusHumansHydrophobic and Hydrophilic InteractionsKineticsPoliovirusPurine NucleosidesStructure-Activity RelationshipVirologyVirus Replication7-deaza-6-methyl-9-ribofuranosylpurineAdenosineAntiviral AgentsPurine Nucleosides

Identifiers

PMID20964406
PMCPMC2990348
OpenAlexW2003965120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.